Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 1
1990 3
1992 5
1993 2
1994 1
1995 1
1996 1
1998 3
1999 2
2000 3
2001 4
2002 3
2003 3
2004 2
2005 3
2006 6
2007 3
2008 4
2009 5
2010 7
2011 9
2012 9
2013 4
2014 9
2015 9
2016 11
2017 24
2018 13
2019 32
2020 42
2021 48
2022 50
2023 44
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
Chen M, Zhu X, Zhang L, Zhao D. Chen M, et al. BMC Med Genomics. 2023 Sep 18;16(1):220. doi: 10.1186/s12920-023-01659-9. BMC Med Genomics. 2023. PMID: 37723519 Free PMC article.
RESULTS: COL5A2 expression was elevated in GC. More than this, the scRNA-seq analysis revealed that COL5A2 expression had a spatial gradient. ...GSEA analyses revealed that COL5A2 was associated with tumor progression-related pathways. Meanwhile, COL5A2
RESULTS: COL5A2 expression was elevated in GC. More than this, the scRNA-seq analysis revealed that COL5A2 expression had a sp …
Phenotype of COL3A1/COL5A2 deletion patients.
Kempers MJ, Wessels M, Van Berendoncks A, van de Laar IM, de Leeuw N, Loeys B. Kempers MJ, et al. Eur J Med Genet. 2022 Oct;65(10):104593. doi: 10.1016/j.ejmg.2022.104593. Epub 2022 Aug 11. Eur J Med Genet. 2022. PMID: 35964930 Free article.
Classical (cEDS) and vascular type (vEDS) are the most prevalent subtypes and are caused by heterozygous pathogenic variants in COL5A1, COL5A2, COL1A1 or, respectively, in COL3A1. We describe 3 cases with contiguous deletions resulting in haploinsufficiency of both genes w …
Classical (cEDS) and vascular type (vEDS) are the most prevalent subtypes and are caused by heterozygous pathogenic variants in COL5A1, C
COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
Ding YL, Sun SF, Zhao GL. Ding YL, et al. Medicine (Baltimore). 2021 Feb 19;100(7):e24561. doi: 10.1097/MD.0000000000024561. Medicine (Baltimore). 2021. PMID: 33607786 Free PMC article.
Through the ROC result, COL5A2 had more advantage as a biomarker for GC than other collagens. CONCLUSIONS: COL5A2 gene expression level might be a risk factor for GC. COL5A2 has a strong correlation with the prognosis of the disease....
Through the ROC result, COL5A2 had more advantage as a biomarker for GC than other collagens. CONCLUSIONS: COL5A2 gene express …
A COL5A2 In-Frame Deletion in a Chihuahua with Ehlers-Danlos Syndrome.
Kiener S, Chevallier L, Jagannathan V, Briand A, Cochet-Faivre N, Reyes-Gomez E, Leeb T. Kiener S, et al. Genes (Basel). 2022 May 23;13(5):934. doi: 10.3390/genes13050934. Genes (Basel). 2022. PMID: 35627319 Free PMC article.
Whole-genome sequencing identified a heterozygous de novo 27 bp deletion in the COL5A2 gene, COL5A2:c.3388_3414del. The in-frame deletion is predicted to remove 9 amino acids in the triple-helical region of COL5A2. The molecular analysis and identification of …
Whole-genome sequencing identified a heterozygous de novo 27 bp deletion in the COL5A2 gene, COL5A2:c.3388_3414del. The in-fra …
Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer.
Feng S, Xu Y, Dai Z, Yin H, Zhang K, Shen Y. Feng S, et al. Front Immunol. 2022 Jul 8;13:951582. doi: 10.3389/fimmu.2022.951582. eCollection 2022. Front Immunol. 2022. PMID: 35874760 Free PMC article.
A machine learning methodology was used to identify COL16A1, COL5A2, GREM1, LUM, SRPX, and TIMP3 and construct a prognostic signature. ...
A machine learning methodology was used to identify COL16A1, COL5A2, GREM1, LUM, SRPX, and TIMP3 and construct a prognostic signature …
Involvement of COL5A2 and TGF-beta1 in pathological scarring.
Ilieș RF, Aioanei CS, Cătană A, Halmagyi SR, Lukacs I, Tokes RE, Rotar IC, Pop IV. Ilieș RF, et al. Exp Ther Med. 2021 Oct;22(4):1067. doi: 10.3892/etm.2021.10501. Epub 2021 Jul 27. Exp Ther Med. 2021. PMID: 34447460 Free PMC article.
This dysregulation may result in various clinical appearances of a lesion, such as skin ulcers, keloids, hypertrophic and atrophic scars. The collagen type V alpha 2 (COL5A2) gene provides a template for a component of type V collagen, found primarily within the skin basem …
This dysregulation may result in various clinical appearances of a lesion, such as skin ulcers, keloids, hypertrophic and atrophic scars. Th …
Classic Ehlers-Danlos Syndrome.
Malfait F, Symoens S, Syx D. Malfait F, et al. 2007 May 29 [updated 2024 Feb 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2007 May 29 [updated 2024 Feb 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301422 Free Books & Documents. Review.
DIAGNOSIS/TESTING: The diagnosis of cEDS is established in a proband with characteristic clinical features and a heterozygous pathogenic variant in COL1A1, COL5A1, or COL5A2 identified by molecular genetic testing. MANAGEMENT: Treatment of manifestations: Dermal wounds are …
DIAGNOSIS/TESTING: The diagnosis of cEDS is established in a proband with characteristic clinical features and a heterozygous pathogenic var …
COL5A2 Inhibits the TGF-beta and Wnt/beta-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of Osteosarcoma.
Han YL, Luo D, Habaxi K, Tayierjiang J, Zhao W, Wang W, Aikebaier W, Wang L. Han YL, et al. Front Oncol. 2022 Feb 24;12:813809. doi: 10.3389/fonc.2022.813809. eCollection 2022. Front Oncol. 2022. PMID: 35280775 Free PMC article.
Furthermore, qRT-PCR and immunofluorescence assays confirmed the high expression of COL5A2 in human osteosarcoma cells. CCK-8 assay and scratch WB was used to determine whether the downregulation of COL5A2 expression inhibits the TGF-beta signaling and Wnt/beta-Cate …
Furthermore, qRT-PCR and immunofluorescence assays confirmed the high expression of COL5A2 in human osteosarcoma cells. CCK-8 assay a …
COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival.
Ren X, Chen X, Fang K, Zhang X, Wei X, Zhang T, Li G, Lu Z, Song N, Wang S, Qin C. Ren X, et al. Front Oncol. 2021 Mar 18;11:583083. doi: 10.3389/fonc.2021.583083. eCollection 2021. Front Oncol. 2021. PMID: 33816226 Free PMC article.
Weighted correlation network analysis (WGCNA) was used, and COL5A2 was selected for further analysis. The results from in vitro experiments demonstrated that COL5A2 was upregulated in PCa with high Gleason scores. The knockdown of COL5A2 inhibited cell prolif …
Weighted correlation network analysis (WGCNA) was used, and COL5A2 was selected for further analysis. The results from in vitro exper …
lncRNA BZRAP1-AS1 alleviates rheumatoid arthritis by regulating miR-1286/COL5A2 axis.
Zhu J, Tu S, Qu Q. Zhu J, et al. Immun Inflamm Dis. 2022 Feb;10(2):163-174. doi: 10.1002/iid3.558. Epub 2021 Nov 11. Immun Inflamm Dis. 2022. PMID: 34766472 Free PMC article.
Luciferase reporter, RIP, and pull-down assays were used to confirm the BZRAP1-AS1/miR-1286/COL5A2 cascade predicted by bioinformatics analysis. RESULTS: BZRAP1-AS1 and COL5A2 were downregulated in RA tissues and RA-HFLS while miR-1286 was amplified. ...Overexpressi …
Luciferase reporter, RIP, and pull-down assays were used to confirm the BZRAP1-AS1/miR-1286/COL5A2 cascade predicted by bioinformatic …
345 results